Follicle-Stimulating Hormone
A follicle-stimulating hormone test measures the amount of follicle-stimulating hormone (FSH) in a blood sample. FSH is produced by the pituitary gland.
- In women, FSH helps control the menstrual cycle and the production of eggs by the ovaries. The amount of FSH varies throughout a woman's menstrual cycle and is highest just before she releases an egg (ovulates).
- In men, FSH helps control the production of sperm. The amount of FSH in men normally remains constant.
The amounts of FSH and other hormones (luteinizing hormone, estrogen, and progesterone) are measured in both a man and a woman to determine why the couple cannot become pregnant (infertility). The FSH level can help determine whether male or female sex organs (testicles or ovaries) are functioning properly.
Why It Is Done
A follicle-stimulating hormone (FSH) test may be done to:
- Help find the cause of infertility. FSH testing
is commonly used to help evaluate a:
- Woman's egg supply (ovarian reserve).
- Man's low sperm count.
- Help evaluate menstrual problems, such as irregular or absent menstrual periods (amenorrhea). This can help determine whether the woman has gone through menopause.
- Determine whether a child is going through early puberty (also called precocious puberty). Puberty is early when it starts in girls younger than age 9 and in boys younger than age 10.
- Determine why sexual features or organs are not developing when they should (delayed puberty).
- Help diagnose certain pituitary gland disorders, such as a tumor.
How To Prepare
Many medicines, such as cimetidine, clomiphene, digitalis, and levodopa, can change your test results. You may be asked to stop taking medicines (including birth control pills) that contain estrogen or progesterone or both for up to 4 weeks before having a follicle-stimulating hormone (FSH) test. Make sure your health professional has a complete list of all the prescription and over-the-counter medicines you are taking, including herbs and natural substances.
Tell your health professional if you have had a test that used a radioactive substance (tracer) within the last 7 days. Recent tests using a radioactive tracer (such as a thyroid scan or bone scan) can interfere with FSH test results.
Let your health professional know the first day of your last menstrual period. If your bleeding pattern is light or begins with spotting, the first day is the day of heaviest bleeding.
Talk to your health professional about any concerns you have
regarding the need for the test, its risks, how it will be done, or what the
results will indicate. To help you understand the importance of this test, fill
out the
medical test information form
(What is a PDF document?)
.
How It Is Done
The health professional drawing your blood will:
- Wrap an elastic band around your upper arm to stop the flow of blood. This makes the veins below the band larger so it is easier to put a needle into the vein.
- Clean the needle site with alcohol.
- Put the needle into the vein. More than one needle stick may be needed.
- Attach a tube to the needle to fill it with blood.
- Remove the band from your arm when enough blood is collected.
- Apply a gauze pad or cotton ball over the needle site as the needle is removed.
- Apply pressure to the site and then a bandage.
For a woman who is having problems with her menstrual cycle or who cannot become pregnant, more than one blood sample may be needed to help identify a follicle-stimulating hormone (FSH) problem. A sample may be taken each day for several days in a row.
WebMD Medical Reference from Healthwise
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.

